Investing
CellFE, a tech-enabled cell engineering platform, and Plenful, a workflow-automation platform for pharmacy operations, also garnered investment.
It also intends to triple its consumer base.
The company will use the funds to enrich its technology, commercialize its MRD product and continue the development of its multi-cancer early detection offering.
The company will use the funds to expand its reach throughout hospitals in the U.S. and enhance product development.
Also, Manipal Global Education Services has launched a super app for medical students.
The company will use the funds to expand internationally, initially focused on the Japanese and Brazilian markets.
The company offers personalized care plans and connects patients with a coordinated care team, including dietitians, internists and gastroenterologists.
Data exchange platform Briya and clinical trial-participant management platform Mural Health also secured investments.
The funds will be used to develop AI-enabled ultrasound technology for maternal care and pediatric lung health in low- and middle-income countries.
The care delivery enablement platform scored $8 million and now has a foothold in New Jersey, Pennsylvania, Texas, Florida and Maryland.